For competition experiments, binding of 1 µM nucleotide free wild-type KRas (referred to as KRasWT in the following) or KRas1–169 G12C C51S C80L C118S (referred to as KRasG12C) to 1 µM mantdGDP or 1 µM mantdGDPβMe in the absence of or the presence of 0.5 µM, 1 µM and 3 µM of competing nucleotides (GDP, GDPβMe, acyclovir or SML-8-73-1) was assessed and the resulting progress curves were globally fit using KinTek Explorer (the corresponding files are available as a supplement and can be opened with KinTek Explorer28 (link) (
SOS catalyzed nucleotide exchange on 200 nM KRas:mantdGDP or KRas:mantdGDPβMe was characterized by exchange with 50 µM GDP in the presence of different concentrations of SOS, the resulting progress curves were fit with a single exponential equation and observed rate constants were plotted against the SOS concentration to obtain kcat/KM from the slope of the linear fit (Fig.
Allosteric activation of SOS was tested by mixing 10 µM KRas:mantdGDP with 1 µM SOS/1 mM GppNHp (Fig.